Zelira Therapeutics Limited (ASX:ZLD)
Australia · Delayed Price · Currency is AUD 0.3400
-0.0100 (-2.86%)
At close: Dec 5, 2025
Zelira Therapeutics Market Cap
Zelira Therapeutics has a market cap or net worth of 4.05 million as of December 5, 2025. Its market cap has decreased by -51.50% in one year.
Market Cap
4.05M
Enterprise Value
6.35M
Revenue
656.00
Ranking
n/a
PE Ratio
n/a
Stock Price
0.34
Market Cap Chart
Since November 22, 2016, Zelira Therapeutics's market cap has decreased from 15.39M to 4.05M, a decrease of -73.72%. That is a compound annual growth rate of -13.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4.05M | -42.50% |
| Dec 31, 2024 | 7.04M | -31.11% |
| Dec 29, 2023 | 10.21M | 6.63% |
| Dec 30, 2022 | 9.58M | -77.35% |
| Dec 31, 2021 | 42.28M | -61.23% |
| Dec 31, 2020 | 109.05M | 161.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.88B |
| Pro Medicus | 26.02B |
| Cochlear | 17.62B |
| Sonic Healthcare | 11.42B |
| Ramsay Health Care | 8.33B |
| Ansell | 5.14B |
| Telix Pharmaceuticals | 5.02B |
| Mesoblast | 3.41B |